Fujirebio expands its assay menu in the field of neurodegenerative diseases with the launch of the fully automated Lumipulse G NfL CSF and Lumipulse G NfL Blood tests

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE

Related Keywords

Fujirebio Europe ,Christiaan De Wilde ,Zetterbergh Neurofilament ,Public Relations Sustainability Department ,Research Use ,Hu Group Holdings Inc ,Lumipulseg Nfl ,Lumipulseg Nfl Blood ,Global Head Neuro ,Holdings Inc ,Neuro Filament Proteins ,Cold Spring Harb Perspect ,Neurol Neurosurg ,Neurofilament Light Chain ,Monitor Neurological Diseases ,Relations Section ,Sustainability Department ,Fujirebio ,Xpands ,Essay ,Menu ,Field ,Neurodegenerative ,Diseases ,Launch ,Bully ,Utomated ,Umipulse ,Flood ,Tests ,